Individual therapy for all cancer patients

June 26, 2012
Individual therapy for all cancer patients

In cancer patients, mortality is generally associated with metastases. The ability to detect “circulating tumor cells” (CTCs) in blood is crucial if we are to uncover the mechanisms that lead to metastases. In the future, it will be possible to screen all cancer patients for CTCs using a new and highly advanced technique known as “the CTCtrap”. The EU has awarded a six million euro grant to an international team led by Leon Terstappen, Professor of Medical Cell Biophysics at the University of Twente, The Netherlands (MIRA Institute). The CTCtrap is expected to be available in about four years’ time. According to Prof. Terstappen “This new technology will bring about a radical change in the treatment of cancer patients.”

The professor, who is the initiator and leader of this international project, had previously developed a technique for extracting CTCs from tubes containing 7.5 ml of blood. The various types of cancer revealed by this test are then analysed and counted. This information can be used to provide therapy that is better tailored to individual patients. This test suffers from the drawback that these tumor cells can be detected in only half of all cancer patients with metastatic disease. CTCs are present in the blood at very low concentrations, so these cells can usually only be detected in patients with cancers that are far advanced.

Individual therapy for all cancer patients

Leon Terstappen comments that “We also want to find out more about ‘that one cell’ that is left behind and that suddenly becomes active years after the primary tumor was treated. To this end, we need to examine a patient’s entire blood volume, and that is where the CTCtrap comes in. The advantage is that this technique can also be useful for patients with early stage disease.”

The project team consists of a consortium of eleven companies, universities, and research institutes from the United Kingdom, France, Italy, Estonia, Germany and the Netherlands. The project’s official date of commencement is September 1, 2012. The first two years will be devoted to the development of a prototype. This work will be carried out by four companies in cooperation with the University of Twente. During the final two years, clinical trials will be carried out in breast cancer patients and prostate cancer patients.

Individual therapy for all cancer patients

The CTCtrap

In addition to chemotherapy, are increasingly being given target specific drugs. After a period of time, drug resistance may occur. A fresh tumour analysis is then needed to determine a new course of treatment. This often involves a biopsy, in which a tissue sample is taken. With the new CTCtrap technique, the patient receives a transfusion of their own treated blood (apheresis). CTCtrap is an acronym for Circulating Tumour Cells TheRapeutic APheresis. All of the patient’s blood (approximately 5.5 litres) is passed through a special filter, before being returned to their body. The filter traps any circulating tumour cells. Techniques are being developed to count these cells and to identify treatments to which they would be susceptible. This approach would allow treatment to be better tailored to the individual. In addition, this technique would enable physicians to treat their patients more quickly. This would increase efficiency and cut costs.

Prof. Terstappen explains: “Our initial approach was to reduce to a minimum the quantity of blood required to reach the right conclusions. I now take the view that we should be examining more , not less.”

Explore further: Blood test provides 'snapshot' of tumor drug response

Related Stories

Blood test provides 'snapshot' of tumor drug response

June 6, 2012
(Medical Xpress) -- Counting the number of tumour cells in blood samples taken before and after treatment for advanced neuroendocrine tumors could provide a ‘snapshot’ of how well patients are responding within ...

Cancer cells in blood predict chances of survival and can help target breast cancer treatment

March 22, 2012
Detecting the presence of circulating tumour cells (CTCs) in the blood of women with early breast cancer after surgery but before the start of chemotherapy can provide useful information about their chances of surviving the ...

Blood test could lead to improved diagnosis and treatment of breast cancer

June 5, 2012
Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.

'Liquid Biopsy': Blood test gives 'real-time' picture of cancer

May 31, 2012
(Medical Xpress) -- A simple and cost-effective blood test could be used to monitor how a patient is responding to treatment and detect genetic faults in their cancer as they happen, according to a Cancer Research UK study.

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.